EPNS Case Discussion – Complex movement disorders in atypical CLN2 disease

27 September 2023

Neuronal Ceroid Lipofuscinosis Type 2 (CLN2) is a rare lysosomal storage disease caused by a deficiency in TPP1 enzyme activity. Lack of disease awareness and the non-specificity of presenting symptoms often contribute to delayed diagnosis. We report a late-onset case of atypical CLN2 disease from West Africa, presenting with a complex movement disorder phenotype in the absence of epilepsy and other classical CLN2 features. We highlight the importance of recognising movement disorders in CLN2 disease, their potentially significant disease burden, and pharmacological treatment challenges. As we improve our understanding of the spectrum of movement disorders associated with CLN2 disease, regular assessment and treatment of movement disorders, especially in atypical forms, should be encouraged.

Further details

The ERNs are co-funded by the
European Union (Health Programme and CEF)

EU Commission

“EURO-NMD is one of the 24 European Reference Networks (ERNs) approved by the ERN Board of Member States. The ERNs are co-funded by the European Union (Health Programme and CEF).
For more information about the ERNs and the EU health strategy,
please visit ec.europa.eu/health/ern